Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1987-04-13
1989-05-09
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514886, 514921, 514 2, 424 942, 424 9464, A61K 3764
Patent
active
048290548
ABSTRACT:
There is disclosed a process for treating gram negative septicemia/endotoxemia to decrease lung damage in a host by parenterally administering a therapeutically effective amount of antithrombin III and alpha-1-proteinase inhibitor.
REFERENCES:
Fritz et al CA 94, 1981, #17257w.
Jachum et al, CA 100, 1984, #136794c.
Okamoto et al, CA 103, 1985, #153649p.
Fuchs et al CA 102, 1985, #3692m.
Koide et al CA 93, 1980 #3030r.
Gitel et al CA 101, 1984, #36651p.
El et al CA 105, 1986, #205150g.
Stockley et al CA 101, 1984, #2741v.
Emerson, Jr. Thomas E.
Redens Thomas B.
Draper Garnette D.
Giblin James A.
Miles Laboratories Inc.
Moskowitz Margaret
Simonton Pamela A.
LandOfFree
Method of decreasing lung damage in a host following the onset o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of decreasing lung damage in a host following the onset o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of decreasing lung damage in a host following the onset o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-90258